PMID- 25841109
OWN - NLM
STAT- MEDLINE
DCOM- 20170404
LR  - 20170404
IS  - 2617-2402 (Electronic)
IS  - 0333-7308 (Linking)
VI  - 52
IP  - 1
DP  - 2015
TI  - Social Anxiety Disorder Comorbid with Schizophrenia: The Importance of Screening 
      for This Under recognized and Under treated Condition.
PG  - 40-5
AB  - BACKGROUND: While the presence of comorbid anxiety disorders such as 
      obsessive-compulsive disorder and panic disorder have been well described in 
      schizophrenia, comorbid social anxiety disorder (SAD) has been less emphasized. 
      The goal of this study was to examine the prevalence of SAD in our ambulatory 
      population of patients with schizophrenia. METHODS: A group of 50 outpatients 
      with schizophrenia randomly selected from our public mental health outpatient 
      population was evaluated with the Structured Clinical Interview for DSM-IV 
      (SCID)-schizophrenia section, the Positive and Negative Syndrome Scale (PANSS), 
      the Schizophrenia Quality of Life Scale (SQLS), the Liebowitz Social Anxiety 
      Scale (LSAS) and the Global Assessment of Functioning Scale (GAF). After 
      completion of assessments, a retrospective chart review was conducted on all 
      study patients who met criteria for a diagnosis of SAD in order to determine how 
      many of these patients had been previously given a diagnosis of SAD. RESULTS: 
      Based on a cutoff score of 29/30 on the total LSAS score, 38% of our sample had a 
      comorbid diagnosis of SAD. Compared to patients who did not suffer from comorbid 
      SAD, patients with schizophrenia and comorbid SAD had lower ratings of quality of 
      life, but similar GAF and PANSS scores. According to the results of the chart 
      review, none of the affected patients had been previously diagnosed with SAD. 
      CONCLUSIONS: According to the results of our study, SAD as a comorbid condition 
      is highly prevalent in schizophrenia and may be under-detected in the outpatient 
      mental health care setting. Furthermore, the presence of SAD may lead to a 
      decreased quality of life for patients with schizophrenia. Further studies should 
      evaluate whether the diagnosis and treatment of comorbid SAD would improve the 
      treatment and quality of life of patients with schizophrenia.
FAU - Lowengrub, Katherine Moss
AU  - Lowengrub KM
AD  - Rehovot Mental Health Center, Rehovot and the Beer Yaakov Mental Health Center, 
      Beer Yaakov, both affiliated with the Sackler School of Medicine, Tel Aviv 
      University, Ramat Aviv, Israel.
FAU - Stryjer, Rafael
AU  - Stryjer R
AD  - Rehovot Mental Health Center, Rehovot and the Beer Yaakov Mental Health Center, 
      Beer Yaakov, both affiliated with the Sackler School of Medicine, Tel Aviv 
      University, Ramat Aviv, Israel.
FAU - Birger, Moshe
AU  - Birger M
AD  - Rehovot Mental Health Center, Rehovot and the Beer Yaakov Mental Health Center, 
      Beer Yaakov, both affiliated with the Sackler School of Medicine, Tel Aviv 
      University, Ramat Aviv, Israel.
FAU - Iancu, Iulian
AU  - Iancu I
AD  - Rehovot Mental Health Center, Rehovot and the Beer Yaakov Mental Health Center, 
      Beer Yaakov, both affiliated with the Sackler School of Medicine, Tel Aviv 
      University, Ramat Aviv, Israel.
LA  - eng
PT  - Journal Article
PL  - Israel
TA  - Isr J Psychiatry Relat Sci
JT  - The Israel journal of psychiatry and related sciences
JID - 8108287
SB  - IM
MH  - Adult
MH  - Comorbidity
MH  - Female
MH  - Humans
MH  - Israel/epidemiology
MH  - Male
MH  - Middle Aged
MH  - Phobia, Social/*diagnosis/epidemiology
MH  - Psychotic Disorders/*diagnosis/epidemiology
MH  - Schizophrenia/*diagnosis/epidemiology
EDAT- 2015/04/05 06:00
MHDA- 2017/04/05 06:00
CRDT- 2015/04/05 06:00
PHST- 2015/04/05 06:00 [entrez]
PHST- 2015/04/05 06:00 [pubmed]
PHST- 2017/04/05 06:00 [medline]
PST - ppublish
SO  - Isr J Psychiatry Relat Sci. 2015;52(1):40-5.